Log In
Print
BCIQ
Print
Print this Print this
 

deferasirox (Exjade) (ICL670)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionIron chelating agent
Molecular Target Not available
Mechanism of ActionChelating agent
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today